The former reflects a proportional decrease in lean tissue during negative energy balance and is typically expected to account for roughly one-quarter of the total weight loss, whereas the latter involves both quantitative loss of skeletal muscle and impaired muscle function or strength [19]
Tirzepatide is an injectable weight loss treatment designed to assist individuals in achieving their weight loss goals
In addition to short-term side effects like nausea and constipation, some patients experience muscle loss and a slowing of their metabolism
10.1016/j.apsb.2024.03.011 31 HernndezC.BogdanovP.CorralizaL.Garca-RamrezM.Sol-AdellC.ArranzJ
However, we used different analytic methods robust to pleiotropy, which gave a similar interpretation
Over time, carriers have shifted from a single broad formulary to more personalized formularies by drug type, tightening criteria and improving cost management